Search

Kening Song

from Marlborough, MA
Age ~71
Get Report
Also known as:
Kenning Song, Kenian Song, Song Kening, G Song, Song Kenning
Phone and address:
31 Crosby Rd, Marlboro, MA 01752
(508) 229-7956
Related to:
Song Zhe, 48Yuhong Zhang, 73
Connected to:
Aeja Song, 55Aijun J Song, 50Alice J Song, 67Alisha M Song, 34Angelina E Song, 32Anita Song, 37Arthur Song, 29Benjamin Song, 76Boram Song, 42Brett H Song, 74

Kening Song Phones & Addresses

  • 31 Crosby Rd, Marlborough, MA 01752 (508) 229-7956
  • Dalton, GA
  • Tuscaloosa, AL

Publications

Us Patents

Neutralizing Antibodies Against Gdf-8 And Uses Therefor

View page
US Patent:
8420082, Apr 16, 2013
Filed:
Dec 7, 2009
Appl. No.:
12/632383
Inventors:
Geertruida M. Veldman - Sudbury MA, US
Monique V. Davies - Harpswell MA, US
Kening Song - Arlington MA, US
Neil M. Wolfman - Dover MA, US
Kristie Grove Bridges - Maynard MA, US
Anne Field - Royston, GB
Caroline Russell - Royston, GB
Viia Valge-Archer - Little Abington, GB
Assignee:
Wyeth LLC - Wilmington DE
International Classification:
A61K 39/00
A61K 39/395
C07K 16/00
C07K 16/18
C07K 16/22
US Classification:
4241301, 4241331, 4241351, 4241411, 4241421, 4241451, 4241581, 5303871, 5303873, 5303881, 53038815, 53038823, 53038824
Abstract:
The disclosure provides novel antibodies against growth and differentiation factor-8 (GDF-8), in particular human antibodies, and antibody fragments, including those that inhibit GDF-8 activity in vitro and/or in vivo. The disclosure also provides methods for diagnosing, preventing, or treating degenerative disorders of muscle or bone, or disorders of insulin metabolism.

Neutralizing Antibodies Against Gdf-8 And Uses Therefor

View page
US Patent:
7261893, Aug 28, 2007
Filed:
Oct 21, 2003
Appl. No.:
10/688925
Inventors:
Geertruida M. Veldman - Sudbury MA, US
Monique V. Davies - Harpswell ME, US
Kening Song - Arlington MA, US
Neil M. Wolfman - Dover MA, US
Kristie Grove Bridges - Maynard MA, US
Anne Field - Herts, GB
Caroline Russell - Herts, GB
Viia Valge-Archer - Cambs, GB
Assignee:
Wyeth - Madison NJ
Cambridge Antibody Technology Limited - Cambridge
International Classification:
A61K 39/395
C12P 21/08
US Classification:
4241451, 4241411, 53038823, 53038824, 5303881
Abstract:
The disclosure provides novel antibodies against growth and differentiation factor-8 (GDF-8), in particular human antibodies, and antibody fragments, including those that inhibit GDF-8 activity in vitro and/or in vivo. The disclosure also provides methods for diagnosing, preventing, or treating degenerative disorders of muscle or bone, or disorders of insulin metabolism.

Neutralizing Antibodies Against Gdf-8 And Uses Therefor

View page
US Patent:
20080044410, Feb 21, 2008
Filed:
Jul 13, 2007
Appl. No.:
11/777525
Inventors:
Geertruida Veldman - Sudbury MA, US
Monique Davies - Harpswell ME, US
Kening Song - Arlington MA, US
Neil Wolfman - Dover MA, US
Kristie Bridges - Maynard MA, US
Anne Field - Royston, GB
Caroline Russell - Royston, GB
Viia Valge-Archer - Little Abington, GB
Assignee:
Wyeth - Madison NJ
Cambridge Antibody Technology Limited - Cambridge
International Classification:
A61K 39/395
A61P 19/00
A61P 19/08
A61P 21/00
C07H 21/02
C07H 21/04
C07K 16/22
C07K 16/44
C12N 15/85
C12N 5/10
US Classification:
424133100, 435320100, 435325000, 530387900, 530388150, 536023530
Abstract:
The disclosure provides novel antibodies against growth and differentiation factor-8 (GDF-8), in particular human antibodies, and antibody fragments, including those that inhibit GDF-8 activity in vitro and/or in vivo. The disclosure also provides methods for diagnosing, preventing, or treating degenerative disorders of muscle or bone, or disorders of insulin metabolism.

Bmp Mutants With Decreased Susceptibility To Noggin

View page
US Patent:
20110039773, Feb 17, 2011
Filed:
Dec 19, 2008
Appl. No.:
12/746821
Inventors:
Moulay Hicham Alaoui-Ismaili - Hopkinton MA, US
Kening Song - Acton MA, US
Assignee:
Stryker Biotech - Hopkinton MA
International Classification:
A61K 38/18
C07K 14/51
C07K 14/475
C07H 21/00
C12N 15/63
A61P 19/08
A61P 19/04
US Classification:
514 88, 530350, 514 76, 536 235, 4353201
Abstract:
The present invention provides modified, highly potent bone morphogenetic proteins. In particular, the present invention relates to the observation that BMP-6 and BMP-9 are less susceptible to inhibition by Noggin that are other members of the BMP subfamily of proteins. The present invention features chimeric bone morphogenetic proteins in which the middle portion of BMP-6 or BMP-9 replaces the middle portion of another BMP subfamily protein to cause resistance to inhibition by Noggin or other Noggin-like antagonists. Other embodiments of modified BMPs, compositions and methods of use are also included.

Neutralizing Antibodies Against Gdf-8 And Uses Therefor

View page
US Patent:
20130287762, Oct 31, 2013
Filed:
Nov 30, 2012
Appl. No.:
13/691395
Inventors:
Geetruida M. Veldman - Sudbury MA, US
Monique V. Davies - Harpswell MA, US
Kening Song - Arlington MA, US
Neil M. Wolfman - Dover MA, US
Kristie Grove - Maynard MA, US
Anne Field - Rayston, GB
Caroline Russell - Royston, GB
Viia Valge-Archer - Little Abington, GB
Assignee:
MEDIMMUNE LIMITED - CAMBRIDGE
WYETH - MADISON NJ
International Classification:
C07K 16/22
US Classification:
4241331, 5303892, 5303873, 4241581, 536 2353, 4353201, 435336, 435 696, 4352523, 4352542
Abstract:
The disclosure provides novel antibodies against growth and differentiation factor-8 (GDF-8), in particular human antibodies, and antibody fragments, including those that inhibit GDF-8 activity in vitro and/or in vivo. The disclosure also provides methods for diagnosing, preventing, or treating degenerative disorders of muscle or bone, or disorders of insulin metabolism.
Control profile
Kening Song from Marlborough, MA, age ~71 Get Report